EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle

Zinger Key Points
  • The distribution strategy for Psyched’s first-to-market product Calm targets over 200,000 retail outlets, says CCO Matthew Singh.
  • The company is developing beverage, pain management, anti-inflammatory, beauty and cosmetic products, slow-release capsules, a tea steeping bag and topical creams for future release, says Singh, who previously worked with Coca-Cola, Red Bull and Vital Pharmaceuticals.

Psyched Wellness Ltd PSYCF plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S.

It’s derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol.

“Everyone knows what this mushroom is by sight. You’ve seen ‘Alice in Wonderland.’ You’ve seen it on your phone. It’s the mushroom emoji,” Psyched Wellness CEO Jeffrey Stevens told the inaugural Benzinga Psychedelics Capital Conference Tuesday in Miami Beach.

Here’s what psychedelics investors need to know.

The Product: Psyched’s first product, a tincture named Calm, will be sold in the U.S. as a food supplement and is intended as a sleep aid.

It’s built on Psyched’s proprietary amanita muscaria extract AME-1. The extraction is key: the reason the mushroom never caught on from a recreational standpoint is that it would make you ill to eat it without any extraction process, the CEO said.

“You can’t put any patents on a mushroom, but you certainly can on the processes,” Stevens said.

Long used by indigenous groups, muscimol acts on the GABAA receptors and is a powerful compound, he said.

“The regulatory landscape for this mushroom is quite unique,” Stevens said, adding that it can be sold over the counter.

What’s Next For Psyched Wellness: The distribution strategy for Psyched’s first-to-market product Calm targets over 200,000 retail outlets, said CCO Matthew Singh.

The company is developing beverage, pain management, anti-inflammatory, beauty and cosmetic products, slow-release capsules, a tea steeping bag and topical creams for future release, said Singh, who previously worked with Coca-Cola Co KO, Red Bull and Vital Pharmaceuticals.

Psyched is planning a commercial vertical with wholesale white label and private label applications of the AME-1 extract, he said.

“We have a wide assortment of what we want to do with this mushroom and its incredible healing power.”

 

Posted In: Amanita MuscariaJeffrey StevensMatthew SinghmuscimolPCCPCC22CannabisNewsPenny StocksPsychedelicsEventsExclusivesMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.